MyAverix Finance
US · Healthcare
Bio Essence Corporation (BIOE)
Drug Manufacturers - Specialty & Generic
Bio Essence Corporation (BIOE) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BIOE
Bio Essence Corporation (BIOE) — FAQ
What is BIOE's P/E ratio?
The price-to-earnings (P/E) ratio for Bio Essence Corporation (BIOE) is 18.00 (data as of 2026-03-23).
Does Bio Essence Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Bio Essence Corporation (BIOE). Check the MyAverix Finance app for the latest dividend data.
What sector is Bio Essence Corporation in?
Bio Essence Corporation (BIOE) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BIOE listed on?
BIOE is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.